title: Cholinergic enhancement increases the effects of voluntary attention but does not affect involuntary attention.
abstract: Voluntary visual spatial attention can be allocated in a goal-oriented manner to locations containing behaviorally relevant information. In contrast, involuntary attention is automatically captured by salient events. Allocation of attention is known to be modulated by release of the neurotransmitter acetylcholine (ACh) in cerebral cortex. We used an anti-predictive spatial cueing task to assess the effects of pharmacological enhancement of cholinergic transmission on behavioral measures of voluntary and involuntary attention in healthy human participants. Each trial began with the presentation of a cue in a peripheral location. In 80% of the trials, a target then appeared in a location opposite the cue. In the remaining 20% of trials, the target appeared in the cue location. For trials with short stimulus onset asynchrony (SOA) between cue and target, involuntary capture of attention resulted in shorter reaction times (RTs) to targets presented at the cue location. For long SOA trials, allocation of voluntary attention resulted in the opposite pattern: RTs were shorter when the target appeared in the expected (opposite) location. Each subject participated in two sessions: one in which the cholinesterase inhibitor donepezil was administered to increase synaptic ACh levels and one in which placebo was administered. Donepezil selectively improved performance (reduced RT) for long SOA trials in which targets appeared in the expected location. Thus, cholinergic enhancement augments the benefits of voluntary attention but does not affect involuntary attention, suggesting that they rely on different neurochemical mechanisms.
authors.affiliation: Helen Wills Neuroscience Institute, University of California, Berkeley, CA 94720-2020, USA. arokem@berkeley.edu
authors.forename: Ariel
authors.initials: A
authors.lastname: Rokem
authors.forename: Ayelet N
authors.initials: AN
authors.lastname: Landau
authors.forename: Dave
authors.initials: D
authors.lastname: Garg
authors.forename: William
authors.initials: W
authors.lastname: Prinzmetal
authors.forename: Michael A
authors.initials: MA
authors.lastname: Silver
mesh_terms: D000328:Adult; D001288:Attention / Q000187:drug effects / Q000502:physiology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003463:Cues; D000077265:Donepezil; D005260:Female; D006801:Humans; D007189:Indans / Q000494:pharmacology; D008297:Male; D010880:Piperidines / Q000494:pharmacology; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D013037:Spatial Behavior / Q000187:drug effects / Q000502:physiology*
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil
references.citation: Eur J Pharmacol. 1999 Dec 10;386(1):7-13
references.pmid: 10611458
references.citation: Psychon Bull Rev. 1994 Dec;1(4):476-90
references.pmid: 24203555
references.citation: Lancet. 2004 Jun 26;363(9427):2105-15
references.pmid: 15220031
references.citation: Trends Cogn Sci. 2006 Jan;10(1):38-45
references.pmid: 16318922
references.citation: Eur J Neurosci. 1999 Oct;11(10):3597-609
references.pmid: 10564367
references.citation: J Neurosci. 1994 Apr;14(4):2313-26
references.pmid: 7512637
references.citation: Spat Vis. 1997;10(4):437-42
references.pmid: 9176953
references.citation: PLoS Med. 2007 Nov 27;4(11):e338
references.pmid: 18044984
references.citation: Eur J Neurosci. 2006 Jul;24(1):314-28
references.pmid: 16882027
references.citation: Spat Vis. 1997;10(4):433-6
references.pmid: 9176952
references.citation: Neuropsychologia. 2008 Mar 7;46(4):1032-40
references.pmid: 18166203
references.citation: Q J Exp Psychol (Hove). 2009 Feb;62(2):352-69
references.pmid: 18609402
references.citation: Percept Psychophys. 1990 Sep;48(3):243-51
references.pmid: 2216651
references.citation: Neurology. 2001 Aug 14;57(3):481-8
references.pmid: 11502917
references.citation: J Neurosci. 2007 Oct 31;27(44):11986-90
references.pmid: 17978039
references.citation: Neuron. 2008 Dec 10;60(5):904-14
references.pmid: 19081383
references.citation: Drugs Aging. 2004;21(1):43-53
references.pmid: 14715043
references.citation: J Exp Psychol Gen. 2005 Feb;134(1):73-92
references.pmid: 15702964
references.citation: Neuroscience. 2006 Feb;137(3):853-64
references.pmid: 16309846
references.citation: J Neurophysiol. 1987 Oct;58(4):765-80
references.pmid: 3681394
references.citation: Schizophr Res. 1996 May;20(1-2):33-50
references.pmid: 8794492
references.citation: Brain Res Brain Res Rev. 2005 Feb;48(1):98-111
references.pmid: 15708630
references.citation: Neuropsychopharmacology. 2008 Mar;33(4):731-8
references.pmid: 17551539
references.citation: J Neurosci. 2005 May 4;25(18):4593-604
references.pmid: 15872107
references.citation: J Exp Psychol. 1980 Jun;109(2):160-74
references.pmid: 7381367
references.citation: Br J Clin Pharmacol. 1998 Nov;46 Suppl 1:1-6
references.pmid: 9839758
references.citation: Nature. 2008 Aug 28;454(7208):1110-4
references.pmid: 18633352
references.citation: Mol Neurobiol. 2007 Oct;36(2):184-200
references.pmid: 17952661
references.citation: Nicotine Tob Res. 2002 May;4(2):185-94
references.pmid: 12028851
references.citation: Neuroscience. 2006 Aug 11;141(1):201-12
references.pmid: 16713104
references.citation: Neuron. 2004 Mar 25;41(6):969-82
references.pmid: 15046728
references.citation: J Neurophysiol. 2007 Jan;97(1):229-37
references.pmid: 16971677
references.citation: Percept Psychophys. 1980 Sep;28(3):241-8
references.pmid: 7433002
references.citation: J Exp Psychol Hum Percept Perform. 1990 Feb;16(1):121-34
references.pmid: 2137514
references.citation: Philos Trans R Soc Lond B Biol Sci. 1982 Jun 25;298(1089):187-98
references.pmid: 6125970
references.citation: Brain Res. 1983 Dec 19;289(1-2):143-55
references.pmid: 6661640
references.citation: J Neurophysiol. 2005 Apr;93(4):2062-72
references.pmid: 15548624
references.citation: Neuroscience. 2002;114(2):451-60
references.pmid: 12204214
references.citation: Neuron. 2007 Oct 4;56(1):141-54
references.pmid: 17920021